Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICUSource: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003
Association of acinetobacter baumannii respiratory isolates with hospital outcomes in ventilated patients Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006
Antibiotic susceptibility patterns of respiratory isolates of gram-negative bacilli in a Turkish university hospital Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007
Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007
Antibiotic susceptibility patterns of respiratory strains of Staphylococcus aureus in a Turkish university hospital Source: Eur Respir J 2003; 22: Suppl. 45, 148s Year: 2003
Antibiotic susceptibility patterns of respiratory strains of pseudomonas species in a Turkish university hospital Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003
Resistance of respiratory isolates of klebsiella pneumoniae from patients in pediatric cardiac surgery department Source: International Congress 2016 – Paediatric respiratory infections Year: 2016
Respiratory infections caused by Pseudomonas aeruginosa in patients admitted in a respiratory care unit Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005
Antibiotic susceptibility testing on streptococcus pneumoniae strains obtained from respiratory tract specimens Source: Eur Respir J 2001; 18: Suppl. 33, 139s Year: 2001
Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005
Acinetobacter baumanii as a severity marker in a respiratory ICUSource: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006
Clinical outcomes of tigecycline in the treatment of critically ill patients with multidrug-resistant Acinetobactor baumannii infection Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005
Antibiotic resistance and nosocomial pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005
Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003
Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs Source: International Congress 2018 – Neonatology and paediatric intensive care Year: 2018
Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Direct LAMP assay from clinical sample for carbapenem resistant A. baumannii Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018